These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25530608)

  • 1. Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010.
    Hounsome LS; Verne J; McGrath JS; Gillatt DA
    Eur Urol; 2015 Jun; 67(6):1056-1062. PubMed ID: 25530608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
    Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
    Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.
    Afshar M; Goodfellow H; Jackson-Spence F; Evison F; Parkin J; Bryan RT; Parsons H; James ND; Patel P
    BJU Int; 2018 Feb; 121(2):217-224. PubMed ID: 28594471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
    Gandaglia G; Popa I; Abdollah F; Schiffmann J; Shariat SF; Briganti A; Montorsi F; Trinh QD; Karakiewicz PI; Sun M
    Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
    Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
    Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Centralised Services on Metric Reflecting High-quality Performance: Outcomes from 1110 Consecutive Radical Cystectomies at a Single Centre.
    Pang KH; Thomas F; Novara G; Din OS; Morgan SL; Hussain SA; Jubber I; Noon AP; Catto JWF; Rosario DJ
    Eur Urol Focus; 2021 May; 7(3):554-565. PubMed ID: 32576531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
    Collins JW; Tyritzis S; Nyberg T; Schumacher M; Laurin O; Khazaeli D; Adding C; Jonsson MN; Hosseini A; Wiklund NP
    Eur Urol; 2013 Oct; 64(4):654-63. PubMed ID: 23769588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
    Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
    BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
    Mayr R; May M; Martini T; Lodde M; Comploj E; Pycha A; Strobel J; Denzinger S; Otto W; Wieland W; Burger M; Fritsche HM
    Eur Urol; 2012 Oct; 62(4):662-70. PubMed ID: 22534059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy.
    Shariat SF; Rink M; Ehdaie B; Xylinas E; Babjuk M; Merseburger AS; Svatek RS; Cha EK; Tagawa ST; Fajkovic H; Novara G; Karakiewicz PI; Trinh QD; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Chun FK; Sonpavde G; Joual A; Scherr DS; Gonen M
    Eur Urol; 2013 Feb; 63(2):371-8. PubMed ID: 22727174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Vavassori I; Barni S
    Eur Urol; 2014 Feb; 65(2):350-7. PubMed ID: 23849998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes.
    Snow-Lisy DC; Campbell SC; Gill IS; Hernandez AV; Fergany A; Kaouk J; Haber GP
    Eur Urol; 2014 Jan; 65(1):193-200. PubMed ID: 24018019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy.
    Nielsen ME; Shariat SF; Karakiewicz PI; Lotan Y; Rogers CG; Amiel GE; Bastian PJ; Vazina A; Gupta A; Lerner SP; Sagalowsky AI; Schoenberg MP; Palapattu GS;
    Eur Urol; 2007 Mar; 51(3):699-706; discussion 706-8. PubMed ID: 17113703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.